论文部分内容阅读
目的:探讨急诊治疗上呼吸道感染的用药合理性。方法:选择我院自2015年8月至2016年7月期间收治的上呼吸道感染患者92例,依据来院就诊时间均为两组。予以抗病毒药物治疗的患者作为参照组,予以抗病毒药物与抗生素联合治疗的患者作为实验组,最后对两组上呼吸道感染患者的临床效果进行统计分析。结果:两组患者经不同方法治疗后,实验组患者与参照组患者治疗总有效率和痊愈时间经检验后未形成统计学意义。比对两组患者的医疗费用,实验组明显较高,组间数据结果检验后呈现统计学意义。结论:上呼吸道感染是否使用抗生素对治疗效果无任何影响,因此临床需加以关注,从而降低耐药株风险发生率。
Objective: To investigate the rationality of emergency treatment of upper respiratory tract infection. Methods: A total of 92 patients with upper respiratory tract infection admitted to our hospital from August 2015 to July 2016 were enrolled in this study. Both groups were divided into two groups. Patients treated with antiviral drugs as a reference group, combined with antiviral drugs and antibiotics in patients as experimental group, and finally the clinical effect of two groups of patients with upper respiratory tract infection were statistically analyzed. Results: After the two groups of patients were treated by different methods, the total effective rate and the recovery time of the patients in the experimental group and the reference group did not reach statistical significance after the test. Compared with the medical expenses of two groups of patients, the experimental group was significantly higher, and the results of inter-group data showed statistical significance. Conclusion: Whether antibiotics are used in upper respiratory tract infection has no effect on the treatment effect, so it is necessary to pay attention to the clinical need and reduce the risk of drug-resistant strains.